CAAS
CRL icon

Capital Asset Advisory Services’s Charles River Laboratories CRL Stock Holding History

Capital Asset Advisory Services’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,087
Closed -$226K – 318
2023
Q2 		$226K Sell
1,087
-200
-16% -$39.8K 0.02% 301
2023
Q1 		$260K Sell
1,287
-63
-5% -$14.3K 0.02% 287
2022
Q4 		$321K Sell
1,350
-1,709
-56% -$373K 0.03% 258
2022
Q3 		$602K Sell
3,059
-1,322
-30% -$285K 0.08% 146
2022
Q2 		$937K Buy
4,381
+82
+2% +$20K 0.1% 137
2022
Q1 		$1.22M Buy
4,299
+663
+18% +$204K 0.13% 105
2021
Q4 		$1.37M Buy
3,636
+203
+6% +$78.9K 0.15% 96
2021
Q3 		$1.42M Buy
3,433
+32
+0.9% +$13.3K 0.16% 87
2021
Q2 		$1.26M Buy
3,401
+355
+12% +$119K 0.14% 100
2021
Q1 		$883K Buy
3,046
+390
+15% +$108K 0.13% 144
2020
Q4 		$664K Buy
2,656
+268
+11% +$63.8K 0.12% 150
2020
Q3 		$541K Sell
2,388
-187
-7% -$38.8K 0.11% 147
2020
Q2 		$541K Buy
2,575
+42
+2% +$6.7K 0.12% 157
2020
Q1 		$408K Buy
2,533
+364
+17% +$54.6K 0.11% 157
2019
Q4 		$376K Buy
+2,169
New +$300K 0.09% 221

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital Asset Advisory Services's CRL Position: Q3 2023 in Review

Capital Asset Advisory Services sold out of Charles River Laboratories (CRL) in Q3 2023, closing a stake of 1,087 shares — an estimated $226K sold.

Capital Asset Advisory Services first reported a position in CRL in Q4 2019 and held it in 15 quarters. The position peaked at $1.42M in Q3 2021. 621 funds tracked by Wall St. Rank hold CRL as of Q3 2023.

  • Capital Asset Advisory Services reported no remaining Charles River Laboratories position as of Q3 2023 after selling out during the quarter.
  • Capital Asset Advisory Services sold 1,087 Charles River Laboratories shares in Q3 2023, an estimated $226K.
  • Capital Asset Advisory Services first reported a position in Charles River Laboratories in Q4 2019 and held it in 15 quarters.
  • Capital Asset Advisory Services's Charles River Laboratories position peaked at $1.42M in Q3 2021.
  • 621 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2023.

Based on Capital Asset Advisory Services's 13F filing for Q3 2023, filed 18 Oct 2023.